Trinidad & Tobago Wellness Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Trinidad & Tobago Wellness Today.

Press releases published on July 7, 2026

Jul. 7, 2026

World First: KFSH Jeddah's Single-Session Stem Cell Protocol Sets a New Global Standard Balancing Donor Safety and Treatment Efficiency

Indeterminate GlobeNewswire

Jul. 7, 2026

WELL Health Announces Proposed TSXV Listing and Concurrent Financing for WELLSTAR, One of Canada’s Leading Healthcare Software and AI Platforms

Indeterminate GlobeNewswire

Jul. 7, 2026

AIM ImmunoTech Announces Release of New CEO Corner Segment Highlighting Growing Momentum Across Pancreatic Cancer Program

Indeterminate GlobeNewswire

Jul. 7, 2026

Privia Health to Report Second Quarter 2026 Results on Thursday, August 6

Indeterminate GlobeNewswire

Jul. 7, 2026

CMMB Expands Global NCD Initiative into Nigeria, Advancing Global Scale

Indeterminate GlobeNewswire

Jul. 7, 2026

Jupiter Neurosciences Strengthens Board with Appointment of Dr. Tomas J. Philipson

Indeterminate GlobeNewswire

Jul. 7, 2026

Veru to Present at 2026 Obesity & Weight Loss Drug Development Summit and Pre-Conference Workshop Day

Indeterminate GlobeNewswire

Jul. 7, 2026

Clinical Excellence in Continuity of Care: Counterpart Assistant (CA) Use Associated With Stronger Performance Across Transitions of Care Measures and Post-Hospitalization Follow-Up

Indeterminate GlobeNewswire

Jul. 7, 2026

Microbot Medical® Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in the Second Quarter of 2026

Indeterminate GlobeNewswire

Jul. 7, 2026

Oragenics Achieves Full Activation of Australian Phase IIa Trial Network — All Three Sites Now Enrolling

Indeterminate GlobeNewswire

Jul. 7, 2026

SkinStylus® Receives New FDA Clearance for the Improvement of Periorbital Wrinkles for All Skin Types

Indeterminate GlobeNewswire

Jul. 7, 2026

Nu-Tek BioSciences présente ses innovations en matière de nutriments cellulaires et son expertise en matières premières lors de la conférence SIMB 2026

Indeterminate GlobeNewswire

Jul. 7, 2026

Spur Therapeutics Announces First Patient Dosed in GALILEO-3 Pivotal Clinical Trial of FLT201 for the Treatment of Gaucher Disease Type 1

Indeterminate GlobeNewswire

Jul. 7, 2026

Breakthrough T1D Awards Grant to Support PRISE‑hATG Study of SAB‑142 in Stage 3 Type 1 Diabetes

Indeterminate GlobeNewswire

Jul. 7, 2026

Eupraxia Pharmaceuticals Strengthens Board with Three Industry Leaders in Drug Development and Commercialization

Indeterminate GlobeNewswire

Jul. 7, 2026

Arnatar Therapeutics Receives China NMPA Clearance to Initiate First-in-Human Study of ART5, a First-in-Class Up-Regulating ASO Designed to Restore Polycystin-1 for the Treatment of ADPKD

Indeterminate GlobeNewswire

Jul. 7, 2026

Independent University of Lille Study Shows Rose Bengal Sodium Produces Opposing Mechanistic Effects at the Same Dose

Indeterminate GlobeNewswire

Jul. 7, 2026

Certara Accelerates Drug Discovery and Development with NVIDIA BioNeMo Agent Toolkit

Indeterminate GlobeNewswire

Jul. 7, 2026

Enlivex Announces 1-for-15 Reverse Stock Split Effective July 9, 2026

Indeterminate GlobeNewswire

Jul. 7, 2026

Acumen Pharmaceuticals to Present Data on Enhanced Brain Delivery™ (EBD™) Technology and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026

Indeterminate GlobeNewswire